No additional genetic variants associated with metabolic disorders that cause increased C8 levels, such as mutations in the ETFA, ETFB, and ETFDH genes, were identified through high-throughput sequencing, leading to a final diagnosis of MCADD. The gene discussed is ETFDH; the disease is medium chain acyl-CoA dehydrogenase deficiency.